PSTX(Delisted)
Poseida TherapeuticsยทNASDAQ
--
--(--)
PSTX fundamentals
Poseida Therapeutics (PSTX) released its earnings on Aug 20, 2020: revenue was -- (YoY 0.00%), beat estimates; EPS was -- (YoY 0.00%), met estimates.
Revenue / YoY
--
0.00%
EPS / YoY
--
0.00%
Report date
Aug 20, 2020
EPS
Revenue
Revenue & Expenses
PSTX has released its 2024 Q3 earnings report, with revenue of 71.75M, reflecting a YoY change of 667.19%, and net profit of 20.23M, showing a YoY change of 163.68%. The Sankey diagram below clearly presents PSTX's revenue sources and cost distribution.
Key Indicators
Poseida Therapeutics (PSTX) key financial stats and ratios, covering profitability, financial health, and leverage.
Poseida Therapeutics (PSTX)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Poseida Therapeutics (PSTX)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Poseida Therapeutics (PSTX)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Poseida Therapeutics (PSTX) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Poseida Therapeutics (PSTX) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
No Data
